Tagged: Bruce Booth

Clinical Development Relay: The Hurdles We Face

Now that I’ve had the chance to settle in to the blogosphere, I’d like to tell you a little more about what I hope to accomplish with “Trials Without Tribulations.” It is obvious to me (and others in the industry, see here, here, and here) that biopharma faces a number of sizable challenges. Tribulations, if… Read more »

Breaking with Bad Culture: Trading Risk-Aversion for Efficiency

A recent article in Nature Reviews Drug Discovery by Jack Scannell and his colleagues at Sanford Bernstein identifies four primary causes of declining pharma R&D productivity, including the “throw money at it” tendency. Scannell and co-authors list the increasing number and scale of clinical trials as secondary symptoms. David Shaywitz provides an excellent recap, and… Read more »